BARIYANGA Jean Damascene
ID:
|
TOXIN GENE PROFILING AND ANTIBIOTIC SUSCEPTIBILITY OF Bacillus cereus ISOLATED FROM RAW BOVINE MILK SOLD WITHIN KAMPALA CAPITAL CITY
REFNo: NS356ES
i. To determine the prevalence of B. cereus in raw bovine milk from the Kampala district
ii. To determine the antibiotic susceptibility patterns of B. cereus isolated from raw bovine milk from the Kampala district
iii. To detect selected toxin encoding genes harboured by B. cereus isolated from raw bovine milk from the Kampala District.
|
Rwanda |
2022-06-22 12:14:52 |
2025-06-22 |
Natural Sciences |
Non-Clinical Trial |
Degree Award |
|
Caroline Fryns
ID:
|
Infant-directed vocalizations in Chimpanzees (Pan troglodytes)
REFNo: NS272ES
There is clear evidence that surrounding and directed vocalizations have a part in the development of the vocal competence of infants. What part each input plays in vocal development is, however, unclear. As such, the overall aim of this study is to investigate further on the presence and the roles of the different vocal inputs available during the vocal development of wild eastern chimpanzees (Pan troglodytes schweinfurthii). More precisely, the study sets out to identify infant-directed vocalizations and characterize its acoustic and structural properties as well as investigate on its function in respect to ISV on the three different levels of vocal acquisition (see Table 1 for a summary of the hypotheses): production, comprehension and usage (Seyfarth & Cheney, 2010).
This study is part of a wider initiative which sets out to understand the evolution of human language and consequently the evolution of the learning mechanisms set in place in parallel throughout closely related species.
|
France |
2022-06-22 12:11:58 |
2025-06-22 |
Natural Sciences |
Non-Clinical Trial |
Degree Award |
|
Moses Joloba Lutaakome
ID: UNCST-2022-R011558
|
Establishment of Quality Assured COVID 19 Specimen Repository to Support Research in Diagnosis, Prevention and Management of SARS CoV 2 in Uganda
REFNo: HS869ES
(i) Establish a biobank of well-annotated and well-characterized samples of various types, collected from positive COVID -19 patients, asymptomatic SARS CoV-2 individuals and suspects.
(ii) Perform SARS CoV-2 full genome sequencing to support molecular epidemiology, track genetic/antigenic diversity in comparison with first sequences deposited in databases
(iii) Conduct performance evaluations of the Xpert Xpress SARS CoV-2 Rapid Diagnostic Test for adoption and adaptation in Uganda.
(iv) Conduct performance evaluations of the select serological assays for adoption and adaptation in Uganda.
(v) Detect SARS CoV-2 RNA in patients’ stool and urine and evaluate their utility as surrogate specimens for COVID-19 diagnosis
(vi) Study select SARS CoV-2 protein and nucleic acid as prognostic markers for COVID-19 severity and or response to treatment.
(vii) Investigate the relationship between levels of BCG vaccine-specific immune responses on the risk of SARS CoV-2 Infection among high-risk individuals, on immune responses against SARS CoV-2 and clinical outcomes of COVID-19 patients.
|
Uganda |
2022-06-21 8:43:52 |
2025-06-21 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Mark-Donald Mwesiga Bikosa
ID:
|
Describing the Current State of Palliative Care in Uganda
REFNo: HS1874ES
â— Determine nationwide palliative care coverage through mapping the availability of basic palliative care services in Uganda;
â— Identify districts/areas without palliative care for targeted intervention;
â— Describe differences in palliative care services in: government vs. private; facilities; rural vs. urban settings; and different geographic locations throughout Uganda;
â— Make recommendations for continued scale up and integration of the mHealth surveillance system in collaboration with the Ministry of Health;
â— Make recommendations at the policy and programmatic levels to continue to enhance palliative care development in Uganda.
|
Uganda |
2022-06-20 8:31:29 |
2025-06-20 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Martha Namusobya Sarah
ID:
|
Prevalence of chronic respiratory symptoms and chronic obstructive pulmonary disease among post-TB patients in Uganda.
REFNo: HS2232ES
3. To determine factors associated with chronic respiratory symptoms and COPD after successful PTB treatment.,2. To determine the prevalence of COPD among participants with chronic respiratory symptoms after successful PTB treatment.,1. To determine the prevalence of chronic respiratory symptoms after successful PTB treatment. ,
|
Uganda |
2022-06-20 8:25:00 |
2025-06-20 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|